HER2-Positive Advanced Gastrointestinal Cancers: Expert Guidance on Leveraging Targeted Agents to Improve Outcomes

Get up to date on the latest guideline recommendations and clinical data regarding testing and treatment strategies for HER2-positive gastric and colorectal cancers with downloadable slides from a live CME-certified satellite symposium at ASCO 2023, an on-demand webcast, and expert commentary on frequently asked questions.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Seagen Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Seagen Inc.